BIO-UV Group S.A.

EPA:ALTUV.PA

1.792 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 21.78618.14724.22423.32827.95817.32716.13519.53212.6420.0120.0094.9940.0080.0053.1043.1042.5452.5452.5452.4062.4062.406
Cost of Revenue 8.137.14521.71522.42324.15616.67114.95218.18812.2040.0080.0063.3860.0050.0031.9461.9461.431.431.431.5181.5181.518
Gross Profit 13.65611.0022.5090.9053.8020.6561.1831.3440.4380.0040.0031.6080.0020.0021.1581.1581.1151.1151.1150.8870.8870.887
Gross Profit Ratio 0.6270.6060.1040.0390.1360.0380.0730.0690.0350.310.3170.3220.3090.4210.3730.3730.4380.4380.4380.3690.3690.369
Reseach & Development Expenses 1.4061.5651.3281.1970.0010.0010.0010.0010.0010.001000.001000000000
General & Administrative Expenses 0000000000000000000000
Selling & Marketing Expenses 0000000000000000000000
SG&A 4.7874.4010.1020.3940.0910.3170.2790.1040.0440.0030.0021.6850.0020.0021.1551.1551.0131.0131.0130.9720.9720.972
Other Expenses 00.404-0.2830.214-0.381-0.088-0.215-0.078-0.2270000000000000
Operating Expenses 6.19311.8530.3850.1810.4720.4050.4930.1830.2710.0040.0031.6850.0020.0021.1551.1551.0131.0131.0130.9720.9720.972
Operating Income 7.4620.1452.1240.7243.3290.2510.691.1620.167-0-0-0.1290-00.0230.0230.0720.0720.0720.5030.5030.503
Operating Income Ratio 0.3430.0080.0880.0310.1190.0140.0430.0590.013-0.009-0.028-0.0260.008-0.0090.0070.0070.0280.0280.0280.2090.2090.209
Total Other Income Expenses Net -6.993-1.655-0.598-0.739-0.319-0.278-0.031-0.382-0.408-0-0-0.013-0-0-0.089-0.089-0.167-0.167-0.167-0.707-0.707-0.707
Income Before Tax 0.469-1.5111.526-0.0153.01-0.0270.6580.795-0.241-0-0-0.142-0-0-0.066-0.066-0.095-0.095-0.095-0.204-0.204-0.204
Income Before Tax Ratio 0.022-0.0830.063-0.0010.108-0.0020.0410.041-0.019-0.036-0.04-0.028-0.014-0.016-0.021-0.021-0.038-0.038-0.038-0.085-0.085-0.085
Income Tax Expense 0.0940.4120.302-0.1210.699-0.1280.070.086-0.11600-0.08200-0.061-0.061-0.084-0.084-0.084-0.011-0.011-0.011
Net Income 0.374-1.0991.2240.1062.3120.1010.5880.709-0.125-0-0-0.0600-0.005-0.005-0.012-0.012-0.012-0.193-0.193-0.193
Net Income Ratio 0.017-0.0610.0510.0050.0830.0060.0360.036-0.01-0.026-0.016-0.0120.0040.003-0.002-0.002-0.005-0.005-0.005-0.08-0.08-0.08
EPS 0.037-0.110.120.0110.230.010.0580.084-0.015-0.039-0.018-0.0080.0030.004-0.001-0.001-0.002-0.002-0.002-0.025-0.025-0.025
EPS Diluted 0.037-0.110.120.0080.220.010.0560.081-0.015-0.039-0.018-0.0080.0030.004-0.001-0.001-0.002-0.002-0.002-0.025-0.025-0.025
EBITDA 2.5280.123.6861.7724.6051.4641.8831.9190.8050-00.285000.2370.2370.2430.2430.2430.7520.7520.752
EBITDA Ratio 0.1160.0070.1520.0930.1640.0890.1090.1070.0820.004-0.0120.0570.0220.0140.0760.0760.0950.0950.0950.3130.3130.313